Ghana Suspends Ebola Vaccine Trial as Locals Complain of Being Used as 'Guinea Pigs'

The Ebola outbreak has killed more than 11,150 people, mainly in Guinea, Liberia and Sierra Leone. There is no licensed treatment or vaccine for Ebola and the World Health Organization (WHO) has endorsed rushing potential ones through trials to try to halt the epidemic. Ghana had agreed to join other countries in hosting trials to test the safety and effects of two experimental vaccines against the Ebola virus. However, the West African nation has suspended a trial for an Ebola vaccine after complaints that locals were being needlessly used as ’guinea pigs’ in a country currently free of the deadly disease.

Ghana had started Phase 1 safety tests on one vaccine developed by US pharmaceutical giant Johnson and Johnson and Denmark’s Bavarian Nordic in the southeastern Volta region, giving volunteers a mobile phone and 20 cedis ($4.7, 4.2 euros) each. But faced with mounting opposition to the trial, Health Minister Alex Segbefia decided to suspend the tests. The Minister’s spokesman Tony Goodman said, "The minister has got a lot of calls from numerous Ghanaians saying that they are not interested in any trial."

Ebola Virus Disease | Ebola Hemorrhagic Fever: Cause Symptoms Diagnosis Treatment
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have identified five types of Ebola or Ebola hemorrhagic fever virus.

Leaders of the ruling National Democratic Congress in the Volta region said, "The trial was a needless experiment. We have cases of malaria, cholera and HIV/AIDS among others. We need vaccines or remedies for these diseases. Why should a country that is not threatened by Ebola risk the lives of its citizens for an unnecessary experiment? We would be grateful if the experiment is cancelled completely to prevent the use of innocent Voltarians as guinea pigs."

The Ghanaian Food and Drugs Authority (FDA) has said, "The vaccines cannot trigger an outbreak of the deadly hemorrhagic fever. Ghana is very close to epidemic areas in West Africa that are still not rid of the virus. Participation in the trials will give crucial information about whether the tested vaccines are safe, well tolerated and capable of stimulating adequate immune responses in people living in Ghana."

Source-AFP

UN Chief Applauds Progress in Fighting Ebola, Warns of Setbacks Due to Lapse in Vigilance
Ban Ki-Moon stressed the importance of community engagement and active surveillance to fight Ebola and urged the UN to continue lending its support.

Kenya Lifts Travel Ban from Liberia After It was Declared Ebola-Free by WHO
However, Doctors Without Borders has urged the government to be cautious until the disease is completely extinguished in neighboring Guinea and Sierra Leone.

Last Year�s Ebola Strain is Less Virulent Than the First One in 1976: NIH Study
Mayinga strain causes rash on Day 4 and extreme illness by Day 5, while Makona strain doesn't cause rashes before Day 6, and severe symptoms till Day 7.